Newborn screening for Duchenne muscular dystrophy: the perspectives of stakeholdersResearch in context

Summary: Background: The rapidly evolving clinical landscape of Duchenne muscular dystrophy (DMD) is driving innovative approaches for early diagnosis through genomic newborn bloodspot screening (NBS). However, the potential impact of these programs on families and healthcare systems remains unexpl...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Charli Ji, Didu S. Kariyawasam, Hugo Sampaio, Michelle Lorentzos, Kristi J. Jones, Michelle A. Farrar
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Elsevier 2024-04-01
Saila:The Lancet Regional Health. Western Pacific
Gaiak:
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2666606524000439